Posts By: Karen Jones

Source MS Trust: Lemtrada (alemtuzumab) should be restricted to people with highly active relapsing-remitting MS according to a review carried out by the European Medicines Agency’s (EMA) drug safety committee. Highly active relapsing-remitting MS covers people who continue to have relapses despite taking at least one disease-modifying drug (DMD) or if MS is worsening rapidly with at least two… Read more »

Source BBC: Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England. It follows new guidelines from the drugs advisory body NICE, which looked at products for several conditions. Charities have welcomed the move, although some campaigners who have been fighting for access to the drugs… Read more »

Source Medical Xpress: Watching immersive 360 videos of icy Arctic scenes helps to relieve intense burning pain and could hold hope for treating chronic pain, a small study has found. Scientists from Imperial College London have found that using virtual reality headsets could combat increased sensitivity to pain, by immersing people in scenes of icebergs, frigid oceans and sprawling icescapes…. Read more »

Source MS Society:  After months of speculation, the UK government has called a general election for Thursday 12 December. But what do people with MS want from our next government? For the next six weeks, parliamentary candidates from a range of political parties will be trying to convince people across the UK to vote for them…. Read more »